BALB/c mice infected with Brucella abortus strain 2308 have 10-fold higher levels of bacteria during the plateau phase of infection (the time period when the number of colony-forming units in vivo remains consistent) than the more resistant C57BL/10 mice. This is due to a cessation of interferon-Q (IFN-Q) production that begins after the first week of infection and continues until the end of the plateau phase at least 6 weeks post infection. Despite the lack of IFN-Q production during this time BALB/c mice are able to prevent an increase in bacterial colony-forming units. Here it was shown that both tumor necrosis factor (TNF)-K and CD8 T cells were involved in controlling bacterial numbers in BALB/c mice during this time. That is, neutralization of TNF-K or depletion of CD8 T cells with monoclonal antibodies resulted in a significant increase in the number of splenic colony-forming units recovered at 3 weeks post infection. In the absence of CD8 T cells there was also a significant increase in splenic macrophages. The role of TNF-K may depend upon the presence of interferon-Q early in the infection since when TNF-K was neutralized in interferon-Q gene knockout mice there was a marked increase in splenic macrophages, NK cells and neutrophils but not a significant increase in colony-forming units. ß
Introduction
BALB/c mice are less able to control infections with the virulent strain Brucella abortus 2308 than C57BL/10 mice, having about 10-fold more bacteria in their spleens during the plateau phase of the infection which occurs between 1 and 6^8 weeks post infection [1, 2] . A number of di¡er-ences in the immune response appear to contribute to this, including an inability to sustain production of interferon-Q (IFN-Q). IFN-Q is important for control in BALB/c mice during the ¢rst week of infection [1, 3] since in its absence there is an increase in bacteria measured at 1 week post infection. However, by 3 weeks post infection the number of colony-forming units recovered is equivalent regardless of whether IFN-Q was present or not and BALB/c mice survive for over 10 weeks in its absence [4] . In contrast, C57BL/6 mice produce IFN-Q throughout the infection and in its absence have increasing numbers of splenic brucellae until they die by 6 weeks post infection [4] .
Here we wished to determine how BALB/c mice control replication of brucellae during the period when IFN-Q does not contribute. It was postulated that the control may be a result of CD8 T cells since the number of CD8 T cells increased in spleens of IFN-Q-de¢cient BALB/c mice between 6 and 10 weeks post infection, the time when IFN-Q normally begins to contribute to controlling the infection again [4] . Moreover, CD8 T cells have been shown to be important in protection against other intracellular microbes by a IFN-Q-independent mechanism [5, 6] and have cytolytic activity against brucella-infected macrophages [7] . A role for tumor necrosis factor (TNF)-K was also postulated since we have shown previously using in vitro assays that endogenous TNF-K is important for activation of macrophages for killing of brucellae in the absence of IFN-Q [8] and others have shown that production of TNF-K can be independent of IFN-Q [9] . More-over, TNF-K has been shown to mediate protection against other intracellular pathogens including primary infection with Leishmania donovani in BALB/c mice [10] and secondary infection with Histoplasma capsulatum in C57BL mice in the absence of IFN-Q [9] .
Materials and methods

In vivo depletion of CD8 T cells or TNF-K
The role of CD8 T cells and TNF-K in vivo was tested by treating BALB/c mice with rat monoclonal antibodies (mAb) reactive with murine TNF-K or CD8 from 24 h prior to infection until 3 weeks post infection by injecting 1.0 mg Ig every 4 days as described by ourselves and others [3, 11] . Control mice were given equivalent amounts of normal rat IgG (Sigma, St. Louis, MO, USA). Anti-TNF mAb (clone MP6-XT22, purchased from ATCC, Rockville, MD, USA with permission from DNAX Corp., San Diego, CA, USA) and anti-CD8 mAb (clone Lyt 2.2, purchased from ATCC) were prepared as ascites in nude mice and puri¢ed by ammonium sulfate precipitation by standard techniques. Normal BALB/c mice and BALB/ c IFN-Q gene-disrupted (BALB/c-Ifg tml@ ) mice were bred in-house using breeding pairs purchased from Jackson Laboratories (Bar Harbor, ME, USA). They were infected at 7^12 weeks of age with 5U10 4 colony-forming units (cfu) of B. abortus strain 2308 by intraperitoneal injection as described [3] . After 3 weeks, mice were sacri¢ced, spleen weights determined, and the spleen was mechanically disrupted and analyzed for cfu of brucellae as well as for the proportion and total number of various cell populations.
Analysis of splenic cell populations
To analyze leukocyte populations in the spleen, an aliquot of splenocytes was used to prepare cytospin slides that were then stained with Leukostat (Fisher Scienti¢c, Pittsburgh, PA, USA). Di¡erential cell analysis based on morphology was performed to identify neutrophils and macrophages. Another aliquot of splenocytes was stained by either direct or indirect immuno£uorescence by standard techniques using mAb reactive with murine CD4 (L3T4), CD8 (Ly-2), MAC1 (M1/70), NK cells (DX5) and QN T cells (GL3) (all mAb from Pharmingen, San Diego, CA, USA). Immuno£uorescence was determined by £ow cytometric analysis using a FACS Calibur (Becton Dickinson, San Jose, CA, USA) and the proportion of positive cells determined using Cell Quest software (Becton Dickinson).
Results and discussion
The results showed that the in vivo depletion of CD8 T cells resulted in a statistically signi¢cant increase in the mean cfu recovered from infected mice ( Fig. 1 ; P 9 0.039 by the Mann^Whitney one-tailed U-test for results pooled from the two experiments) when compared to the cfu recovered from mice given control IgG. There was also an increase in spleen weight (a measurement that normally correlates with cfu/spleen) although it was not signi¢cant compared to mice given control IgG. There was, however, a signi¢cant increase in the total number of MAC1 cells in the spleens of mice treated with anti-CD8 mAb ( Table  1 ). The signi¢cant in£ux of macrophages observed in the anti-CD8-treated mice in this study is likely to be in response to the increased number of bacteria that occurred in the absence of CD8 T cells and to re£ect an attempt to compensate for the absence of these cells. There was no signi¢cant di¡erence or change in any of the other leukocyte populations in the spleens of the anti-CD8-treated mice compared to control mice except that CD8 T cells were absent indicating that the anti-CD8 mAb treatment was e¡ective and sustained in vivo throughout the 3 weeks of the experiment. Depletion of TNF-K in vivo also resulted in a signi¢cant increase in cfu at 3 weeks post infection ( Fig. 1; P 9 0.027 by the Mann^Whitney one-tailed U-test for results pooled from the two experiments). There was no signi¢cant increase in spleen weight (Fig. 1) or signi¢cant change in any of the splenic leukocyte populations in the anti-TNF-K-treated mice (Table 1) . A second set of identical experiments evaluated the role of TNF-K in BALB/c IFN-Q genedisrupted mice. When TNF-K was depleted in IFN-Q genedisrupted mice there was also an increase in cfu recovered from the spleens in both experiments performed (Fig. 2) , although the magnitude of increase was less than that observed in normal mice and the e¡ect was not statistically signi¢cant (P v 0.05). There was no increase in spleen weight in the anti-TNF-K mAb-treated IFN-Q gene-disrupted mice (Fig. 2) but there was nearly a 10-fold increase in the MAC1 cells, NK cells and PMN in their spleens compared to that in mice not given anti-TNF-K mAb (Table 1). This latter result suggested that these cells of the innate immune system were involved in the control of the infection, or at least attempting to control the infection, in the absence of both TNF-K and IFN-Q.
The results presented here are in agreement with studies that showed CD8 T cells contribute to control of infections with the attenuated vaccine strain B. abortus 19 in both C57BL/10 and CBA mice [7, 12] and with those of Winter and colleagues who demonstrated that CD8 T cells collected from spleens of BALB/c mice 8 weeks post infection could transfer resistance to strain 19 infections to naive mice [13] . However, since by 8 weeks post infection IFN-Q may be being produced again in BALB/c mice infected with strain 19 it cannot be ruled out that the role for CD8 T cells in protection at that time was through secretion of IFN-Q. In contrast, during the plateau phase of infection the role of CD8 T cells in controlling bacteria must be by an IFN-Q-independent mechanism such as cytotoxicity. The results presented here are in contrast with those in another study in which we found perforin-mediated and class I-restricted T cell responses were not important in C57BL/6 strains of mice for resistance to infections with strain 2308 after the ¢rst week of infection [4] . We postulate that the di¡erence in the role for CD8 T cells between the two strains of mice occurs because C57BL/6 mice sustain production of IFN-Q throughout the brucella infection. Thus, other mechanisms of immunity, such as cytolytic activity by CD8 T cells, would be likely to be secondary.
The results presented here also indicated that TNF-K played a role in control of infections with the virulent 2308 strain of B. abortus during the plateau phase in BALB/c mice. The results obtained with IFN-Q gene-disrupted mice also suggested that the mechanism of TNF-Kmediated immunity may be partially dependent upon production of IFN-Q prior to the 3 week time point. It is known from previous studies that IFN-Q is produced and does contribute to control in BALB/c mice during the ¢rst week after infection [1] even though for some weeks subsequently it does not [4] . It is possible that the IFN-Q produced in the ¢rst week of infection is necessary to establish TNF-K-mediated protective mechanisms that persist despite the subsequent demise of IFN-Q production. Thus in the complete absence of IFN-Q there was a reduced ability to observe an additional role for TNF-K. While we were unable to demonstrate a signi¢cant increase in cfu in the IFN-Q gene-disrupted mice depleted of TNF-K the signi¢cant changes in splenic cell populations involved in innate immunity suggested that TNF-K does normally contribute to control.
There are several possible mechanisms by which TNF-K may contribute to protection in BALB/c mice. It has been previously demonstrated that brucella-infected mice lacking the receptor for TNF-K are de¢cient in IL-12 production [14] , suggesting TNF-K mediates IL-12 production. IFN-Q-independent mechanisms for IL-12 in protective immunity against leishmania have been reported by others [10] . TNF-K is also known to have a role in nitric oxide production [15] , albeit the contribution of nitric oxide for control of brucella infections is unresolved [8] . Finally, as indicated above, we have shown that TNF-K is involved in the activation of macrophages for brucellacidal activity even in the absence of IFN-Q activation [8] and thus contributes to the initial decrease in intracellular brucellae following phagocytosis. It is possible that a coordinated e¡ort by TNF-K and CD8 T cells prevents an increase in total brucellae per spleen despite the inability to actually clear the infection. Following phagocytosis of brucellae by non-IFN-Q-activated macrophages, a large proportion of the bacteria are killed [16] . Eventually those not killed begin to replicate and it is this that is thought to be responsible for sustaining the chronic infection. We postulate that if infected macrophages are lysed by cytotoxic CD8 T cells then the brucellae would be continually reexposed to phagocytes activated by TNF-K and the number of bacteria again reduced following phagocytosis. In this way the number of bacteria could be kept constant throughout the plateau phase, although ultimately clearance of the infection and thus survival of BALB/c mice infected with strain 2308 requires IFN-Q [4] .
